Penn Medicine Abramson Cancer Center


 

UPenn ASH Highlights on CAR-T & Bispecific Antibodies for iNHL: Are Axi-Cel/Tisa-Cel Effective in FL & MZ? How Beneficial Are Mosunetuzumab/Odronextamab in R/R FL?

187 views
March 2, 2021
0 Comments
Login to view comments. Click here to Login
New Therapies and Current Patient Management of Lymphomas